Navigation Links
Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
Date:12/11/2008

available at www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements about the results of the company's Vaxfectin(R)-formulated H5N1 influenza DNA vaccine Phase 1 clinical trial and the results of nonclinical mouse studies of Vaxfectin(R)-formulated influenza vaccines produced by the company's RapidResponse(TM) manufacturing system. Risks and uncertainties include whether Vical or others will continue development of the H5N1 pandemic influenza vaccines or the RapidResponse(TM) DNA vaccine platform; whether H5N1 influenza DNA vaccine Phase 1 clinical trial results will be confirmed in larger studies; whether nonclinical results from mouse studies will advance to human clinical testing, and if so, whether such testing will yield similar results; whether the company will receive all of the NIH grant funding; whether DNA vaccines against H5N1 influenza or any other targets will be successfully developed and commercialized; whether Vical or its collaborative partners will seek or gain approval to market the influenza vaccine or any other product candidates; whether Vical or its collaborative partners will succeed in marketing any product candidates; whether Vical or others will secure funding to advance the pandemic influenza DNA vaccine program; whether any product candidates will be shown to be safe and efficacious in clinical trials; the timing of clinical trials; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update th
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
2. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
3. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
4. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
5. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
6. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
7. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
9. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
10. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
11. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... --  ICD-10 Charts ( www.icd10charts.com ) announced today ... officially launched its newest line of ICD-10 preparation ... new 4 Step ICD-10 Implementation Plan.  Both of ... Charts resources and mobile apps, are available to ... the release of these resources, the company has ...
(Date:7/7/2015)... DALLAS , July 7, 2015 ... report The report "Nuclear Medicine/Radiopharmaceuticals Market by Type ... (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - ... Forecasts to 2020", published by MarketsandMarkets, this report ... forecast period of 2015 to 2020. This market ...
(Date:7/7/2015)... 30, 2015 ... the addition of the "Biomedical Photoacoustic ... offering. This patent landscape focuses ... is a safe, non-invasive, non-ionizing imaging technique. ... a great alternative to traditional medical imaging ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3
... A recently issued patent extends protection of the ... selling medical thermometer brand, the TemporalScanner™ Temporal Artery ... Patent No. 7,787,938, entitled, "Temporal Artery Temperature Detector" ... to the already extensive Exergen portfolio of valuable ...
... 17, 2011 ACC Booth # 2001 -- Further ... Inc. is pleased to announce the availability of its ... support system, ISR will be featured along with the ... College of Cardiology (ACC) 2011 Annual Scientific ...
Cached Medicine Technology:Exergen Granted New Patent for Temporal Artery Thermometers 2Fujifilm's Exclusive Software Advances Cardiovascular Reporting Capabilities 2Fujifilm's Exclusive Software Advances Cardiovascular Reporting Capabilities 3
(Date:7/7/2015)... , ... July 07, 2015 , ... ... into everyday items, recently launched their first line of luxury smart jewelry called ... and is expected to ship this fall. , “The Socialite collection was ...
(Date:7/7/2015)... ... July 07, 2015 , ... More than ... Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy Association's ... $100,000, to help support children fighting muscular dystrophy and related life-threatening diseases ...
(Date:7/7/2015)... ... July 07, 2015 , ... This week Northeast ... brand new website. The website’s goal is to provide patients with detailed information ... tools, including requesting appointments online. , Part of the center’s rebranding efforts, the ...
(Date:7/7/2015)... ... ... Greatist today announced the acquisition of Blood, Sweat & ... fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s leadership ... events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, Sweat ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading ... aims to give back to the community through company-wide volunteering efforts. , On an ... dedicate the day to assisting those in need throughout Baltimore and Washington D.C. ...
Breaking Medicine News(10 mins):Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2
... Medicare Fraud Strike Force, WASHINGTON, April 30 ... late yesterday of Medicare fraud,Assistant Attorney General Alice S. ... Acosta of the Southern District of Florida,announced today., ... Caos, 62, guilty on all,charged counts, including: conspiracy to ...
... "Opportunities for,Next-Generation Implants," the 2008 Materials and ... the diverse innovators who,envision, create and apply ... Hosted by Cleveland Clinic and ASM ... forum will bring together surgeons,clinicians, biomedical engineers, ...
... (IPF) patients learn from specialists,seek answers about incurable ... announcement,was released by The Coalition for Pulmonary Fibrosis:, ... for Patients and Their,Families, Beth Israel Deaconess ... Pulmonary Fibrosis (CPF), is hosting a free seminar ...
... 30 West Pharmaceutical,Services, Inc., (NYSE: WST ) ... of Shareholders. The meeting will be held on Tuesday, ... live webcast can be accessed through the "Investor" section ... extra time prior,to the live webcast to visit the ...
... all holders of a valid press card / formal journalist ... facilities, including a working room, and the press office will ... experts. , You can register for free ... any queries to the EULAR Press Office on eularpressoffice@uk.cohnwolfe.com ...
... of multi-national data, released this month, reveals that highly ... educated women, but that the meaning of healthier changes ... malnutrition is prevalent, better-educated women weigh more. But in ... better-educated women weigh less. , As a ...
Cached Medicine News:Health News:Miami Jury Convicts Dermatologist of Medicare Fraud 2Health News:Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 3Health News:West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast 2Health News:Better-educated women are a healthier weight, new research reveals 2
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
Used for intermittent self-catheterization of the urethra. The flared proximal end allows the attachment of a syringe for bladder irrigation. Supplied sterile in peel-open packages. Reusable. Intende...
... test for the detection and semi-quantitation ... human serum. ANCA are found in ... vasculitides and hence, serve as an ... laboratory findings in the diagnosis of ...
... is engineered to distribute contact pressure evenly over ... back, to maximize stability and patient comfort. ... readily conformable to patient anatomy, to provide a ... wool liner is standard on both units, as ...
Medicine Products: